NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

SALIENT:

jfr1611

Friday, June 17, 2022 8:45:22 AM

Re: jesster64 post# 487659

Post#
487665
of 487707
When the publication is out, the company will be free to talk. They will defend themselves against AF. I’m hearing lawsuits, criminal (DOJ) & civil ($$).
I expect the publication to go way deeper in the analysis (ie way more data), + the peer review signed by 70 co authors will eliminate all doubts regarding the success of the 17 year trial.

I also think most BP have signed an NDAs with NWBO. After the publication, theses NDAs will fall.
Should we expect an hostile take over shortly after the journal?
Low probability but I can’t eliminate that from my scenario.
If not, JVs for sure.
JV with an “s” because the platform has multiple opportunities.

More likely MHRA will approve DCVax-L very soon in the UK.

I’m hearing also that a short squeeze could potentially bring the stock to the stratosphere…

The sp will be much higher very soon but considering the company knows the results for quite sometimes, I’m sure they are prepared for the next step.